![](/img/cover-not-exists.png)
PND33 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
Hammes, F, Wakeford, C, Gitlin, M, Snyder, SVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.2000
Date:
October, 2018
File:
PDF, 377 KB
english, 2018